MTOR and endometrial carcinoma: A study also showed that HSPB7 was downregulated in endometrial carcinoma (EC) and influenced EC cell proliferation and metastasis via the PI3K/AKT/mTOR signaling pathway (Xing, Wu & Wang, 2023).